Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Myocarditis After SARS-CoV2-Vaccination: An International Patient Registry on Clinical Manifestations and Outcomes

NCT05268458 is registered in ClinicalTrials.gov with Theresien Hospital Mannheim as lead sponsor.

NCT NCT05268458
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05268458 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Myocarditis After SARS-CoV2-Vaccination: An International Patient Registry on Clinical Manifestations and Outcomes
Lead sponsor
Theresien Hospital Mannheim
Phase
Observational
Overall status
Unknown status
Start date
November 12, 2021
Completion date
June 30, 2022
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myocarditis and cardiomyopathy